| Entry |
|
|---|
| Name |
Finafloxacin (INN);
Xtoro (TN)
|
|---|
| Formula |
C20H19FN4O4
|
|---|
| Exact mass |
398.139
|
|---|
| Mol weight |
398.3877
|
|---|
| Structure |
   |
|---|
| Class |
|
|---|
| Efficacy |
Antibacterial, Nucleic acid biosynthesis inhibitor |
|---|
| Comment |
Fluoroquinolones
|
|---|
| Target |
|
|---|
| Interaction |
|
|---|
| Brite |
USP drug classification [BR:br08302]
Antibacterials
Quinolones
Finafloxacin
D10575 Finafloxacin (INN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10575
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10575
 |
|---|
| Other DBs |
|
|---|
| LinkDB |
 |
|---|
| KCF data |
ATOM 29
1 C8y C 22.6800 -16.8000
2 N4y N 23.8700 -17.5000
3 C8y C 21.4900 -17.5000
4 C8y C 22.6800 -15.4000
5 C1y C 23.8700 -18.9000
6 C8x C 25.1300 -16.8000
7 C8y C 20.2300 -16.8000
8 C8y C 23.8700 -14.7000
9 C8x C 21.4900 -14.7000
10 C1x C 24.5700 -20.0900
11 C1x C 23.1700 -20.0900
12 C8y C 25.1300 -15.4000
13 N1y N 19.1100 -17.7100
14 C8y C 20.2300 -15.4000
15 O5x O 23.8700 -13.3700
16 C6a C 26.3200 -14.7000
17 C1x C 18.2700 -16.5900
18 C1x C 18.2700 -18.8300
19 X F 19.0400 -14.7000
20 O6a O 27.5100 -15.4000
21 O6a O 26.3200 -13.3700
22 C1y C 16.9400 -17.0100
23 C1y C 16.9400 -18.4100
24 O2x O 15.6800 -16.3100
25 N1x N 15.7500 -19.1100
26 C1x C 14.4900 -17.0100
27 C1x C 14.4900 -18.4100
28 C3b C 21.5072 -18.8999
29 N3a N 21.5072 -20.2999
BOND 33
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 4 8 1
8 4 9 2
9 5 10 1
10 5 11 1
11 6 12 2
12 7 13 1
13 7 14 2
14 8 15 2
15 12 16 1
16 13 17 1
17 13 18 1
18 14 19 1
19 16 20 1
20 16 21 2
21 17 22 1
22 18 23 1
23 22 24 1
24 23 25 1
25 24 26 1
26 25 27 1
27 8 12 1
28 9 14 1
29 10 11 1
30 22 23 1
31 26 27 1
32 3 28 1
33 28 29 3
|
|---|
